Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qingxiang Shao"'
Autor:
Meixiang Xiang, Honggang Lou, Zhourong Ruan, Jian'an Wang, Jin-liang Chen, Bo Jiang, Qingxiang Shao, Xue-hua Zhang
Publikováno v:
The Journal of Clinical Pharmacology. 54:1144-1152
Hyzetimibe (HS-25) is a new cholesterol absorption inhibitor. We performed the first-in-human study to assess the safety, tolerability, and pharmacokinetics (including the effect of food) and pharmacodynamics (effect on blood lipid level) following s
Publikováno v:
In Contraception 2000 62(1):15-18
Publikováno v:
Pharmaceutical Research. 22:1989-1996
The aim of this study was to develop quantitative structure–activity/pharmacokinetic relationships (QSAR/QSPKR) for a series of synthesized 1,4-dihydropyridines (DHPs) and pyridines as P-glycoprotein (P-gp) inhibitors. Molecular descriptors of test
Autor:
Zhourong, Ruan, Bo, Jiang, Jinliang, Chen, Xuehua, Zhang, Honggang, Lou, Meixiang, Xiang, Qingxiang, Shao, Jian'an, Wang
Publikováno v:
Journal of clinical pharmacology. 54(10)
Hyzetimibe (HS-25) is a new cholesterol absorption inhibitor. We performed the first-in-human study to assess the safety, tolerability, and pharmacokinetics (including the effect of food) and pharmacodynamics (effect on blood lipid level) following s
Autor:
Qingxiang Shao, Zhouhua Ji, Meiyun Zhang, Cheng Yu, Jieyu Dai, Ping Liu, Fang Xu, Jiang Zhen, Hao Yuan, Bin Huang, Chuan Li, Fajun Nan, Jian Cui
Publikováno v:
Rapid communications in mass spectrometry : RCM. 16(19)
Fluoxetine (F) and its N-demehylated metabolite norfluoxetine (NF) are selective inhibitors of serotonin reuptake in humans. A new sensitive rapid method for the simultaneous determination of F and NF in plasma was established and validated, and was